Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Andreozzi, , Amadeo,
DOB: 09-APR-2007 (Age: 18)
Gender: male
Address:
Canale Riccardo, 887 Appartamento 1
23887 Valle San Nicolao (Italy)
ID: 9798-276056-9 (ECI)
Report
Date: 05-DEC-2021
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Ospedale San Leopoldo Mandic
Largo Beato Leopoldo Mandic 1
23807 Merate (Italy)
Specimen
Collected: 05-DEC-2021

Hematology

Test 05-DEC-2021 Reference Range Unit
Leukocytes [#/volume] in Blood by Automated count 6.7 4.5 - 10.5 10*3/uL
Erythrocytes [#/volume] in Blood by Automated count 5.5 4.5 - 6.2 10*6/uL
Hemoglobin [Mass/volume] in Blood 16.5 13.5 - 17.5 g/dL
Hematocrit [Volume Fraction] of Blood by Automated count 36.7 L 38 - 50 %
MCV [Entitic volume] by Automated count 81.2 76 - 98 fL
MCH [Entitic mass] by Automated count 32.6 27 - 34.5 pg
MCHC [Mass/volume] by Automated count 35.1 31 - 37 g/dL
Erythrocyte distribution width [Entitic volume] by Automated count 44.2 36 - 55 fL
Platelets [#/volume] in Blood by Automated count 351.9 H 150 - 350 10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count 286.6 H 13.4 - 17.4 fL
Platelet mean volume [Entitic volume] in Blood by Automated count 11.4 9.4 - 12 fL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The results show a mildly decreased hematocrit, slightly elevated platelet count, and markedly increased platelet distribution width, while other parameters are within normal limits. These findings may suggest mild hemodilution or early reactive thrombocytosis, but there is no evidence of anemia or leukocytosis. Correlation with clinical context and follow-up may be considered if symptoms or risk factors are present.